Bottom line
FPHAX vs JEHSX: the short answer
FPHAX (Pharmaceuticals Portfolio) and JEHSX (Health Sciences Trust) are both mutual funds.
But JEHSX is far broader, holding 173 positions to 57 for FPHAX, so beyond the top names it adds exposure FPHAX doesn't have.
FPHAX is cheaper at 0.67% vs 1.04% — a difference of $37 a year per $10,000 invested.
Over five years, FPHAX returned +12.6% a year vs +4.2% for JEHSX (reporting dates differ).
Updated Nov 19, 2026
FPHAX vs JEHSX side by side
| FPHAX | JEHSX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Fidelity | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.67% | 1.04% |
| Annual cost per $10k | $67 | $104 |
| 10-yr cost on $10k (prospectus) | $835 | $1,282 |
| Max front load | — | — |
| 12b-1 fee | 0% | 0.05% |
| 1-yr return | +30.3% | +19.5% |
| 5-yr return (annualized) | +12.6% | +4.2% |
| 10-yr return (annualized) | +10.0% | +8.7% |
| Best quarter | +18.5% | +23.6% |
| Worst quarter | −13.6% | −16.1% |
| Net assets (fund) | $1.5B | $251.3M |
| Number of holdings | 57 | 173 |
| Portfolio turnover | 77% | 68% |
| Returns as of | Apr 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | FPHAX | JEHSX | Difference |
|---|---|---|---|
| 2025 | +30.3% | +19.5% | +10.8% |
| 2024 | +9.4% | +1.8% | +7.6% |
| 2023 | +12.5% | +4.3% | +8.3% |
| 2022 | +1.0% | −13.1% | +14.1% |
| 2021 | +11.8% | +11.2% | +0.6% |
| 2020 | +11.1% | +27.2% | −16.1% |
| 2019 | +31.6% | +28.7% | +3.0% |
| 2018 | +5.8% | +0.7% | +5.1% |
| 2017 | +10.7% | +27.5% | −16.8% |
| 2016 | −16.3% | −10.6% | −5.7% |
Source: Fund prospectus bar charts
Holdings overlap
5 of FPHAX's top 25 holdings also appear in JEHSX's top 25.
| Holding | FPHAX | JEHSX |
|---|---|---|
| ELI LILLY and CO | 28.78% | 14.30% |
| MERCK and CO INC | 4.74% | 4.21% |
| Gilead Sciences Inc | 3.97% | 2.95% |
| JOHNSON and JOHNSON | 3.77% | 6.33% |
| Moderna Inc | 1.57% | 0.87% |
Source: SEC Form N-PORT
FPHAX top 10
- ELI LILLY and CO — 28.78%
- Gsk Plc — 8.17%
- Viatris Inc — 5.45%
- Ucb Sa — 5.09%
- MERCK and CO INC — 4.74%
- Roche Holding Ag — 4.54%
- Legend Biotech Corp — 4.53%
- Astrazeneca Plc — 4.22%
- Elanco Animal Health Inc — 4.15%
- Jazz Pharmaceuticals Plc — 4.09%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between FPHAX and JEHSX?
Which is cheaper, FPHAX or JEHSX?
Should I own both FPHAX and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.